A single, slightly lower dose is unlikely to have a noticeable impact on your overall metabolic health
For those using semaglutide for weight management (where Wegovy is the licensed product in the UK), the brief interruption is unlikely to significantly impact long-term outcomes, and safe resumption takes priority over continuity of treatment
BioMed Research International, 2012, 153626
Glucagon-like peptide-1 (GLP-1) is a hormone naturally produced in the body that regulates appetite and blood sugar
For example, the lifestyle capsules contain caffeine, which can offer some health benefits, such has reducing risk factors for cardiovascular disease and other chronic conditions ( The capsules include the probiotic Lactobacillus acidophilus , which may help improve gut health in people with irritable bowel syndrome
[28] mhra.gov.uk or via the Yellow Card app), which helps monitor the safety of medicines and supplements in the UK